4//SEC Filing
Sperzel John J III 4
Accession 0000950170-24-017071
CIK 0001492674other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:00 PM ET
Size
6.8 KB
Accession
0000950170-24-017071
Insider Transaction Report
Form 4
Sperzel John J III
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-02-20+160→ 333 total - Exercise/Conversion
Restricted Stock Units
2024-02-20−160→ 160 total→ Common Stock (160 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On February 20, 2022 the reporting person was granted 480 RSU's that vest in three equal annual installments commencing on February 20, 2023
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001602618
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:00 PM ET
- Size
- 6.8 KB